Skip to main content
. Author manuscript; available in PMC: 2019 Jan 15.
Published in final edited form as: Cancer. 2017 Oct 10;124(2):426–433. doi: 10.1002/cncr.31047

Table 3.

U.S. Region of Hospice Use by Cancer Reporting Facility Location.

U.S. Region
Hospice Use All
Regions
n=21,860
Northeast

n=3481
Southeast

n=5526
Midwest

n=7846
Southwest

n=1682
West

n=3163
Ever Enrollment 15,369 (70.3) 2218 (63.9) reference 4209 (77.0) p<0.001 5477 (70.3) p<0.001 1207 (71.5) p<0.001 2191 (68.9) p<0.001
Hospice days, last month of life, mean (SE) 20 (11.6) 18.9 (0.25) reference 20.6 (0.18) p<0.001 19.1 (0.16) p=0.50 20.2 (0.33) p=0.001 20.4 (0.26) p<0.001
Enrollment last month of lifea 8125 (52.9) 1221 (55.6) reference 2117 (50.0) p<0.001 3009 (55.0) p=0.67 616 (51.0) p=0.01 1130 (51.8) p=0.01
Enrollment last 3 days of lifea 2253 (14.7) 389 (17.8) reference 518 (11.5) p<0.001 899 (16.0) p=0.06 163 (13.3) p=0.001 280 (12.9) p<0.001
Chemotherapy last 2 weeks of lifea 1341 (12.9) 220 (13.3) reference 286 (11.3) p=0.06 500 (12.8) p=0.56 105 (12.9) p=0.77 212 (12.9) p=0.68

Values are n(%) unless otherwise noted; Marginal effects at the means are reported using age, sex, race, marital status, income, FCI, CCI, year of cancer diagnosis, cancer stage and histology as covariates;

a

. Denominator is patients ever enrolled in hospice.

Abbreviations: SE= standard error; 162 patients from reporting facilities located in the Philippines, US Virgin Islands or Puerto Rico were excluded.